Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eisenstein, T.K., and M.E. Hilburger, Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations, J. Neuroimmunol. 83:36 (1998).
Flores, L.R., M.C. Hernandez, and B.M. Bayer, Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors, J. Pharmacol. Exp. Ther. 268:1129 (1994).
Weber, R.J., B. Ikejiri, K.C. Rice, A. Pert, and A.A. Hagan, Opiate receptor mediated regulation of the immune response in vivo, N1DA Res. Mono. Ser. 48:341 (1987).
Bussiere, J.L., M.W. Adler, T.J. Rogers, and T.K. Eisenstein, Differential effects of morphine and naltrexone on the antibody response in various mouse strains, Immunopharmacol. Immunotoxicol. 14:657 (1992).
Bryant, H.U., E.W. Bernton, and J.W. Holaday, Immunosuppressive effects of chronic morphine treatment in mice, Life Sci. 41:1731 (1987).
Bussiere, J.L., M.W. Adler, T.J. Rogers, and T.K. Eisenstein, Cytokine reversal of morphine-induced suppression of the antibody response, J. Pharmacol. Exp. Ther. 264:591 (1993).
Louria, D.B, T. Hensle, and J. Rose, The major medical complications of heroin addiction, Ann. Int. Med. 67:1 (1967).
Hussey, H.H., and S. Katz, Infections resulting from narcotic addiction, Am. J. Med. 9:186 (1950).
Scheidegger, C., and W. Zimmerli, Infectious complications in drug addicts: seven year review of 269 hospitalized narcotic abusers in Switzerland, Rev. Infect. Dis. 11:486 (1989).
Haverkos, H.W., and R.W. Lange, Serious infections other than human immunodeficiency virus among intravenous drug users, J. Infect. Dis. 161:894 (1990).
Horsburgh, C.R., R.A. Anderson, and E.J. Boyko, Increased incidence of infections in intravenous drug use, Infect. Control Hosp. Epidemiol. 10:211 (1989).
Jacobs, J.L., J.W.M. Gold, H.W. Murray, R.B. Roberts, and D. Armstrong, Salmonella infections in patients with the acquired immunodeficiency syndrome, Ann. Int. Med. 102:186 (1985).
Glaser, J.B., L. Morton-Kute, and S.R. Berger, Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome, Ann. Int. Med. 102:189 (1985).
Levine, W.C., J.W. Buehler, N.H. Bean, and R.V. Tauxe, Epidemiology of nontyphoidal Salmonella bacteremia during the human immunodeficiency virus epidemic, J. Infect. Dis. 164:81 (1991).
Sperber, S.J., and C.J. Schleupner, Salmonellosis during infection with human immunodeficiency virus, Rev. Infect. Dis. 9:925 (1987).
Gruenewald, R., S. Blum, and J. Chan, Relationship between human immunodeficiency virus infection and Salmonellosis in 20-to 59-year-old residents of New York City, Clin. Infect. Dis. 18:358 (1994).
Celum, C.L., R.E. Chaisson, G.W. Rutherford, J.L. Barnhart, and D.F. Echenberg, Incidence of Salmonellosis in patients with AIDS, J. Infect. Dis. 156:998 (1987).
Angulo, F.J., and D.L. Swerdlow, Bacterial enteric infections in persons infected with human immunodeficiency virus, Clin. Infect. Dis. 21:S84 (1995).
Hoiseth, S.K., and B.A.D. Stocker, Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines, Nature 291:238 (1981).
Killar, L.M., and T.K. Eisenstein, Immunity to Salmonella infection in C3H/HeJ and C3H/HeNCrlBR mice: studies using an aromatic-dependent live Salmonella strain as a vaccine, Infect. Immun. 47:605 (1985).
Mishell, R.I., and R.W. Dutton, Immunization of dissociated spleen cell cultures from normal mice, J. Exp. Med. 126:423 (1967).
Cunningham, A., and A. Szenberg, Further improvements in the plaque technique for detecting single antibody producing cells, Immunology 14:599 (1968).
MacFarlane, A.S., X. Peng, J.J. Meissler, Jr., T.J. Rogers, E.B. Geller, M.W. Adler, and T.K. Eisenstein, Morphine increases susceptibility to oral Salmonella typhimurium infection, J. Infect. Dis. 181:in press (April issue) (1999).
Kromer, W., Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion, Pharmacol. Rev. 40:121 (1988).
Manara, L., and A. Bianchetti, The central and peripheral influences of opioids on gastrointestinal propulsion, Ann. Rev. Pharmacol. Toxicol. 25:249 (1985).
Ruoff, H.-J., B. Fladung, P. Demol, and T.R. Weihrauch, Gastrointestinal receptors and drugs in motility disorders, Digestion 48:1 (1991).
Culpepper-Morgan, J.A., M.J. Kreek, P.R. Holt, D. LaRoche, J. Zhang, and L. O’Bryan, Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig, Life Sci. 42:2073 (1988).
Pol, O., I. Ferrer, and M.M. Puig, Diarrhoea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice, J. Pharmacol. Exp. Ther. 270:386 (1994).
Roy, S., H. Liu, and H.H. Loh, mu-opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit, Mol. Brain Res. 56:281 (1988).
Pol, O., L. Valle, P. Sánchez-Bláquez, J. Garzón, and M.M. Puig, Antibodies and antisense oligodeoxynucleotides to mu-opioid receptors selectively block the effects of mu-opioid agonists on intestinal transit and permeability in mice, Brit. J. Pharmacol. 127:397 (1999).
Hilburger, M.E., M.W. Adler, A.L. Truant, J.J. Meissler, Jr., V. Satishchandran, T.J. Rogers, and T.K. Eisenstein, Morphine induces sepsis in mice, J. Infect. Dis. 176:183 (1997).
Carter, P.B., and F.M. Collins, The route of enteric infection in normal mice, J. Exp. Med. 139:1189 (1974).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Eisenstein, T.K. et al. (2002). Effect of Opioids on Oral Salmonella Infection and Immune Function. In: Friedman, H., Klein, T.W., Madden, J.J. (eds) Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases. Advances in Experimental Medicine and Biology, vol 493. Springer, Boston, MA. https://doi.org/10.1007/0-306-47611-8_20
Download citation
DOI: https://doi.org/10.1007/0-306-47611-8_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46466-9
Online ISBN: 978-0-306-47611-2
eBook Packages: Springer Book Archive